Please use this identifier to cite or link to this item:
|Title:||The Global Epidemiology of Impetigo: A Systematic Review of the Population Prevalence of Impetigo and Pyoderma.|
|Authors:||Bowen, Asha C|
Hay, Roderick J
Andrews, Ross M
Steer, Andrew C
Tong, Steven Y C
Carapetis, Jonathan R
|Affiliation:||Menzies School of Health Research, Charles Darwin University, Darwin, Northern Territory, Australia; Department of Infectious Diseases, Princess Margaret Hospital for Children, Perth, Western Australia, Australia; Telethon Kids Institute, University of Western Australia, Perth, Western Australia, Australia..|
Department of Dermatology, Hôpital Pasteur, Colmar, France..
International Foundation for Dermatology, London, United Kingdom; Skin Infection Clinic, Kings College Hospital NHS Trust, Denmark Hill, United Kingdom..
Menzies School of Health Research, Charles Darwin University, Darwin, Northern Territory, Australia..
Royal Children's Hospital, Melbourne, Victoria, Australia; Institute for Child Health Research, University of Melbourne, Victoria, Australia..
Menzies School of Health Research, Charles Darwin University, Darwin, Northern Territory, Australia; Department of Infectious Diseases, Royal Darwin Hospital, Darwin, Northern Territory, Australia..
Department of Infectious Diseases, Princess Margaret Hospital for Children, Perth, Western Australia, Australia; Telethon Kids Institute, University of Western Australia, Perth, Western Australia, Australia..
|Citation:||PloS one 2015; 10(8): e0136789|
|Abstract:||We conducted a comprehensive, systematic review of the global childhood population prevalence of impetigo and the broader condition pyoderma. PubMed was systematically searched for impetigo or pyoderma studies published between January 1 1970 and September 30 2014. Two independent reviewers extracted data from each relevant article on the prevalence of impetigo. Sixty-six articles relating to 89 studies met our inclusion criteria. Based on population surveillance, 82 studies included data on 145,028 children assessed for pyoderma or impetigo. Median childhood prevalence was 12·3% (IQR 4·2-19·4%). Fifty-eight (65%) studies were from low or low-middle income countries, where median childhood prevalences were 8·4% (IQR 4·2-16·1%) and 14·5% (IQR 8·3-20·9%), respectively. However, the highest burden was seen in underprivileged children from marginalised communities of high-income countries; median prevalence 19·4%, (IQR 3·9-43·3%). Based on data from studies published since 2000 from low and low-middle income countries, we estimate the global population of children suffering from impetigo at any one time to be in excess of 162 million, predominantly in tropical, resource-poor contexts. Impetigo is an under-recognised disease and in conjunction with scabies, comprises a major childhood dermatological condition with potential lifelong consequences if untreated.|
Research Support, Non-U.S. Gov't
|Appears in Collections:||NT Health digital library|
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.